BlackRock Investment Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-123,243
Closed -$363K 4140
2016
Q1
$363K Buy
123,243
+23,305
+23% +$125K ﹤0.01% 3016
2015
Q4
$818K Buy
99,938
+51
+0.1% +$412 ﹤0.01% 2735
2015
Q3
$713K Buy
99,887
+4,562
+5% +$38.1K ﹤0.01% 2850
2015
Q2
$874K Buy
95,325
+16,221
+21% +$156K ﹤0.01% 2872
2015
Q1
$748K Buy
79,104
+6,065
+8% +$58.4K ﹤0.01% 2723
2014
Q4
$711K Sell
73,039
-921
-1% -$9.28K ﹤0.01% 2784
2014
Q3
$704K Buy
73,960
+302
+0.4% +$3.38K ﹤0.01% 2766
2014
Q2
$969K Buy
73,658
+4,626
+7% +$58.3K ﹤0.01% 2629
2014
Q1
$918K Buy
69,032
+6,469
+10% +$85.2K ﹤0.01% 2570
2013
Q4
$609K Buy
62,563
+2,019
+3% +$19K ﹤0.01% 2856
2013
Q3
$593K Buy
60,544
+9,295
+18% +$92.3K ﹤0.01% 2814
2013
Q2
$463K Buy
+51,249
New +$537K ﹤0.01% 2886

Other funds holding CDMO

BlackRock Investment Management's CDMO Position: Q2 2016 in Review

BlackRock Investment Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2016, closing a stake of 123,243 shares — an estimated $363K sold.

BlackRock Investment Management first reported a position in CDMO in Q2 2013 and held it in 12 quarters. The position peaked at $969K in Q2 2014. 76 funds tracked by Wall St. Rank hold CDMO as of Q2 2016.

  • BlackRock Investment Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • BlackRock Investment Management sold 123,243 Avid Bioservices, Inc. Common Stock shares in Q2 2016, an estimated $363K.
  • BlackRock Investment Management first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 12 quarters.
  • BlackRock Investment Management's Avid Bioservices, Inc. Common Stock position peaked at $969K in Q2 2014.
  • 76 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2016.

Based on BlackRock Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.